Visualization of a primary anti-tumor immune response by positron emission tomography. - Wikidata - awgldk - TriplyDB

Visualization of a primary anti-tumor immune response by positron emission tomography.

Visualization of a primary anti-tumor immune response by positron emission tomography.

http://www.wikidata.org/entity/Q34133717

about

Non-invasive imaging of phosphoinositide-3-kinase-catalytic-subunit-alpha (PIK3CA) promoter modulation in small animal models PET probes for distinct metabolic pathways have different cell specificities during immune responses in mice Monte Carlo simulations of absorbed dose in a mouse phantom from 18-fluorine compounds.Quantum mechanics/molecular mechanics investigation of the mechanism of phosphate transfer in human uridine-cytidine kinase 2.Longitudinal, noninvasive imaging of T-cell effector function and proliferation in living subjects.Positron emission tomography with computed tomography imaging of neuroinflammation in experimental autoimmune encephalomyelitis.Structure-guided engineering of human thymidine kinase 2 as a positron emission tomography reporter gene for enhanced phosphorylation of non-natural thymidine analog reporter probe.Noninvasive detection of tumor-infiltrating T cells by PET reporter imaging.Imaging virus-associated cancer.Enhanced sensitivity to IL-2 signaling regulates the clinical responsiveness of IL-12-primed CD8(+) T cells in a melanoma model Targeted molecular imaging in oncology: focus on radiation therapy.Genetic modification of T cells for immunotherapy.Anti-tumor activity and trafficking of self, tumor-specific T cells against tumors located in the brain Real-time imaging of the cellular interactions underlying tolerance, priming, and responses to infection.Non-invasive imaging of adaptive immunity using positron emission tomography.Quantitative PET reporter gene imaging of CD8+ T cells specific for a melanoma-expressed self-antigen.Noninvasive imaging of cell-mediated therapy for treatment of cancer.Molecular imaging of lymphoid organs and immune activation by positron emission tomography with a new [18F]-labeled 2'-deoxycytidine analog.Monitoring the efficacy of adoptively transferred prostate cancer-targeted human T lymphocytes with PET and bioluminescence imaging.Use of nuclear magnetic resonance-based metabolomics in detecting drug resistance in cancer Nuclear imaging of cancer cell therapies The current role of PET-CT in the characterization of hepatobiliary malignancies.Imaging the immune response to monitor tumor immunotherapy.Imaging aspects of the tumor stroma with therapeutic implications.Reporter gene imaging of immune responses to cancer: progress and challenges.Positron emission tomography reporter genes and reporter probes: gene and cell therapy applications.Advances in PET Detection of the Antitumor T Cell Response.PET imaging to non-invasively study immune activation leading to antitumor responses with a 4-1BB agonistic antibody Modulating metastasis by a lymphangiogenic switch in prostate cancer.Epidermal growth factor receptor antibody plus recombinant human endostatin in treatment of hepatic metastases after remnant gastric cancer resection Flow optimization study of a batch microfluidics PET tracer synthesizing device.Tumor-associated macrophages, nanomedicine and imaging: the axis of success in the future of cancer immunotherapy.Importance of [18F]fluorodeoxyglucose-positron emission tomography scanning for the monitoring of responses to immunotherapy in follicular lymphoma.Functional imaging in the immune system

P2860

Q28485978-20A016DD-56BD-4EC2-A478-B9236D033479 Q33881305-51C5EA9C-E02B-4C28-A8D0-E955B830BF68 Q34425601-A7E480BF-46C6-460B-AEBE-E2A2DDD8A935 Q34624976-61DF629E-B359-4BE3-8FA9-B71DE7E63042 Q34676977-C4A6E336-3640-4481-82E9-7A9CCA9CB0CB Q35613716-356D7207-448C-4188-9168-B1B5B6C467CD Q35643725-1689BD80-730F-4F53-BB59-C1F1624D87B5 Q35719906-4E894853-9F8B-411F-8A30-B587B0F443D4 Q36015054-21E1F898-6326-46AC-B022-7B101B2FFF0A Q36494531-8E68EBDE-FE1C-4427-8FDB-85456C2B0D2B Q36528175-E531171C-A206-4921-8F74-A4C1510D678F Q36909362-F723FCB6-F28C-4F77-A2BA-EA276D7B768E Q37037932-E8AF398E-BAC4-49F5-8933-C99A83479AE3 Q37084889-3399A7D7-6934-4B64-9FBE-D78AD777E7B9 Q37084904-4B4AD0A8-D8B8-44C1-BE3E-A68F60A226B6 Q37090163-B5BCE065-4DA7-4C8F-BB16-D51BCCFC570C Q37181560-737E42FB-E214-4E13-A43F-D6B0333176D5 Q37286965-262E51A7-15B1-4C94-BD72-594AD36AFE30 Q37372552-8213B916-418C-4999-B8F5-995B5FB67252 Q37374479-AD782DCE-ABFC-4FCE-9C76-90C485B5F4AD Q37518962-457EC08D-E434-46EC-9048-1F389F0647E1 Q37546832-2DE2401D-139D-4062-A874-D1D7937E4204 Q37608319-961B01EC-D264-4B25-A2E2-AC67BFEB466C Q37626064-39BF7FAD-D375-4BEF-A069-1214A431D7D6 Q38003152-DE861A44-70AF-4668-AAB2-918FA4BADF27 Q38003153-FE3ABD15-D413-4A67-AA39-FDF0A79A8770 Q38846891-9DA96995-84AC-4C4D-85F9-6867D0E84E1C Q39575747-13EE4ED0-5DA6-463A-9181-86F801C0B82C Q39618556-F09D594C-2680-4EDE-9B8D-E7ECFBBD9FCF Q42094544-C39F869A-DD3B-4F86-9B05-ABD55AEA3EA2 Q42582019-065026F3-241A-47DB-8E8E-42A3D0074F3D Q47962563-FD71C478-8493-4549-9B3C-912F7DDCA104 Q53497334-02CDF272-EABC-4C5C-999C-49E7B942C98E Q58003046-87DD72A8-320F-4287-9E7A-7C718C6E6B07

P2860

Visualization of a primary anti-tumor immune response by positron emission tomography.

http://www.wikidata.org/entity/Q34133717

description

2005 nî lūn-bûn

@nan

2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Visualization of a primary anti-tumor immune response by positron emission tomography.

@ast

Visualization of a primary anti-tumor immune response by positron emission tomography.

@en

Visualization of a primary anti-tumor immune response by positron emission tomography.

@nl

type

label

Visualization of a primary anti-tumor immune response by positron emission tomography.

@ast

Visualization of a primary anti-tumor immune response by positron emission tomography.

@en

Visualization of a primary anti-tumor immune response by positron emission tomography.

@nl

prefLabel

Visualization of a primary anti-tumor immune response by positron emission tomography.

@ast

Visualization of a primary anti-tumor immune response by positron emission tomography.

@en

Visualization of a primary anti-tumor immune response by positron emission tomography.

@nl

P1433

Q34133717-57965446-A71F-4043-9FA8-CC521D68EB9D

P1476

Q34133717-6A804C9D-BBEA-4B4D-B725-EBD383FAF251

P2093

Q34133717-1E93411B-60E5-4C09-A7B8-444B3B691AD4

Q34133717-4F95554F-DD54-4FDA-9FEB-11567E034B80

Q34133717-641B3F1D-BAF3-417F-8234-10C22470A59D

Q34133717-664651AD-1B3A-4242-BF78-DC1E821C7759

Q34133717-6E85ED2D-1FD9-44F3-98EB-AC25C8906B75

Q34133717-846D413F-0008-45CC-962C-BF28365F57CA

Q34133717-D866AD3D-4BA8-4830-8549-7ED8CA2AB012

Q34133717-E6BBBDC4-0ED5-4510-B580-F27198520C34

P2860

Q34133717-0BB97629-07F7-4355-9355-688F1B7EEEDF

Q34133717-0C2FE01B-683E-4E47-ABC1-86A3A1A9BB86

Q34133717-0F5CCFD0-09EB-4880-A17A-2EB4B8D33164

Q34133717-1222B1C8-9B8D-49C1-86B1-CC2CC7BE9156

Q34133717-14F509DA-4A39-4BBB-A858-F7C0EBD1D30A

Q34133717-256DB741-3C76-4874-8481-5AB4205AE03A

Q34133717-270F56BB-E767-4C7F-B472-FE0C033BD6FF

Q34133717-2FFBBE38-1121-4242-938F-2807ED5A15D6

Q34133717-3045CFBD-3A83-4B03-A11D-A4FA43E1560A

Q34133717-49B9923E-6B4C-4FDB-98CC-26A0AC7CE80C

P304

Q34133717-652DB499-1F52-4BBE-B300-8E7D913EDE25

P31

Q34133717-925080C2-53E4-467D-8F6F-D290204244C8

P356

Q34133717-17A64E95-4324-407B-A1C6-6B1709524997

P407

Q34133717-66438EA7-9ED0-4D23-9276-295A2A646D83

P433

Q34133717-9C295B52-96B5-4146-9CEC-BAEDEE6EF3C3

P478

Q34133717-3D5CEE0D-8D38-4085-A408-85C7A4E8EB96

P50

Q34133717-A1A905D1-0633-4556-B220-217962F2C961

P577

Q34133717-746CC7BC-0677-4F6F-851E-BC8950FDF4DD

P5875

Q34133717-FE4D925F-9086-4469-B64B-0E920A5C545D

P698

Q34133717-469643EF-4E2F-4F4B-8738-A81AF2CC53C8

P921

Q34133717-37725927-21AC-43D0-BD9C-F6501FFCA52B

P932

Q34133717-6B46D939-F363-4E89-AB0C-CA6CD56BD78F

P356

PNAS.0508698102

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Visualization of a primary anti-tumor immune response by positron emission tomography

@en

P2093

Amar Nijagal

http://www.w3.org/2001/XMLSchema#string

Chengyi J Shu

http://www.w3.org/2001/XMLSchema#string

Owen N Witte

http://www.w3.org/2001/XMLSchema#string

Pritha Ray

http://www.w3.org/2001/XMLSchema#string

Sanjiv S Gambhir

http://www.w3.org/2001/XMLSchema#string

Shuling Guo

http://www.w3.org/2001/XMLSchema#string

Stephanie M Shelly

http://www.w3.org/2001/XMLSchema#string

Young J Kim

http://www.w3.org/2001/XMLSchema#string

P2860

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors

A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography.

Lymphocyte trafficking and regional immunity.

Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways.

Optical imaging of Renilla luciferase reporter gene expression in living mice.

The developing role of cytokines for imaging inflammation and infection.

Quantitative imaging of the T cell antitumor response by positron-emission tomography.

The CD28 signaling pathway regulates glucose metabolism.

Differential uptake of (18)F-fluorodeoxyglucose by experimental tumors xenografted into immunocompetent and immunodeficient mice and the effect of immunomodification.

P304

17412-17417

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0508698102

http://www.w3.org/2001/XMLSchema#string

P407

P433

48

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-11-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7474353

http://www.w3.org/2001/XMLSchema#string

P698

16293690

http://www.w3.org/2001/XMLSchema#string

P921

P932

1283986

http://www.w3.org/2001/XMLSchema#string